A detailed history of Allegheny Financial Group LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Allegheny Financial Group LTD holds 9,462 shares of ABBV stock, worth $1.84 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
9,462
Previous 7,568 25.03%
Holding current value
$1.84 Million
Previous $1.38 Million 17.71%
% of portfolio
0.47%
Previous 0.43%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $293,172 - $342,359
1,894 Added 25.03%
9,462 $1.62 Million
Q1 2024

May 07, 2024

BUY
$159.82 - $182.1 $7,991 - $9,105
50 Added 0.67%
7,568 $1.38 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $21,740 - $24,485
158 Added 2.15%
7,518 $1.17 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $442,717 - $512,510
3,314 Added 81.91%
7,360 $1.1 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $447,088 - $556,372
-3,374 Reduced 45.47%
4,046 $545,000
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $59,868 - $68,947
-414 Reduced 5.28%
7,420 $1.18 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $27,247 - $32,676
-197 Reduced 2.45%
7,834 $1.27 Million
Q3 2022

Nov 01, 2022

SELL
$134.21 - $153.93 $23,755 - $27,245
-177 Reduced 2.16%
8,031 $1.08 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $9,082 - $11,547
-66 Reduced 0.8%
8,208 $1.26 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $35,634 - $44,212
-270 Reduced 3.16%
8,274 $1.34 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $107 - $135
1 Added 0.01%
8,544 $1.16 Million
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $4,149 - $4,710
39 Added 0.46%
8,543 $922,000
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $36,718 - $40,906
-349 Reduced 3.94%
8,504 $958,000
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $3,375 - $3,716
33 Added 0.37%
8,853 $958,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $709,921 - $958,469
8,820 New
8,820 $945,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Allegheny Financial Group LTD Portfolio

Follow Allegheny Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allegheny Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Allegheny Financial Group LTD with notifications on news.